| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |